A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis von Mrowietz, U., de Jong, E.M.G.J., Kragballe, K., Langley, R., Nast, A., Puig, L., Reich, K., Schmitt, J., Warren, R.B.

Volltext

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice von van der Schoot, L.S., Janssen, J.J., Bastiaens, M.T., de Boer-Brand, A., Christiaansen-Smit, C., Enomoto, D.N.H., Hovingh, R., Tupker, R.A., Seyger, M.M.B., Verhoef, L.M., van den Reek, J.M.P.A., de Jong, E.M.G.J.

Volltext

Comment on “Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis” von van den Reek, J.M.P.A, Kievit, W, de Jong, E.M.G.J

Volltext

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes von Van Lingen, R.G., Van De Kerkhof, P.C.M., Seyger, M.M.B., De Jong, E.M.G.J., Van Rens, D.W.A., Poll, M.K.P., Zeeuwen, P.L.J.M., Van Erp, P.E.J.

Volltext

Image‐based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks von Schaap, M.J., Cardozo, N.J., Patel, A., Jong, E.M.G.J., Ginneken, B., Seyger, M.M.B.

Volltext

Predictors of perceived stigmatization in patients with psoriasis von Beugen, S., Middendorp, H., Ferwerda, M., Smit, J.V., Zeeuwen‐Franssen, M.E.J., Kroft, E.B.M., Jong, E.M.G.J., Donders, A.R.T., Kerkhof, P.C.M., Evers, A.W.M.

Volltext

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV... von Reich, K., Zschocke, I., Bachelez, H., Jong, E.M.G.J., Gisondi, P., Puig, L., Warren, R.B., Ortland, C., Mrowietz, U.

Volltext

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etan... von Zweegers, J., van den Reek, J.M.P.A., van de Kerkhof, P.C.M., Otero, M.E., Kuijpers, A.L.A., Koetsier, M.I.A., Arnold, W.P., Berends, M.A.M., Weppner-Parren, L., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., van Lümig, P.P.M., Driessen, R.J.B., Kievit, W., de Jong, E.M.G.J.

Volltext

Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic von Winden, M.E.C., Klösters, F.M., Hamaker, M., Olde Rikkert, M.G., Kerkhof, P.C.M., Jong, E.M.G.J., Lubeek, S.F.K.

Volltext

Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observati... von Bruins, F.M., Bronckers, I.M.G.J., Cai, R., Groenewoud, J.M.M., Krol, M., Jong, E.M.G.J., Seyger, M.M.B.

Volltext

Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis von van der Schaft, J., Politiek, K., van den Reek, J.M.P.A., Christoffers, W.A., Kievit, W., de Jong, E.M.G.J., Bruijnzeel-Koomen, C.A.F.M., Schuttelaar, M.L.A., de Bruin-Weller, M.S.

Volltext

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network von van den Reek, J.M.P.A., Zweegers, J., Kievit, W., Otero, M.E., van Lümig, P.P.M., Driessen, R.J.B., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., Koetsier, M.I.A., Arnold, W.P., Sybrandy-Fleuren, B.A.M., Kuijpers, A.L.A., Andriessen, M.P.M., van de Kerkhof, P.C.M., Seyger, M.M.B., de Jong, E.M.G.J.

Volltext

Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups von Winden, M.E.C., Haar, E.L.M., Groenewoud, J.M.M., Kerkhof, P.C.M., Jong, E.M.G.J., Lubeek, S.F.K.

Volltext

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease von Mertens, J.S., Seyger, M.M.B., Kievit, W., Hoppenreijs, E.P.A.H., Jansen, T.L.Th.A., van de Kerkhof, P.C.M., Radstake, T.R.D., de Jong, E.M.G.J.

Volltext

A review of different ways to assess rosacea von Logger, J.G.M., Vries, F.M.C., Erp, P.E J., Jong, E.M.G.J., Peppelman, M., Driessen, R.J.B.

Volltext

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature von Winden, M.E.C., Garcovich, S., Peris, K., Colloca, G., Jong, E.M.G.J., Hamaker, M.E., Kerkhof, P.C.M., Lubeek, S.F.K.

Volltext

Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis von Reek, J.M.P.A., Coenen, M.J.H., L'Isle Arias, M., Zweegers, J., Rodijk‐Olthuis, D., Schalkwijk, J., Vermeulen, S.H., Joosten, I., Kerkhof, P.C.M., Seyger, M.M.B., Zeeuwen, P.L.J.M., Jong, E.M.G.J.

Volltext

评估酒渣鼻的不同方法回顾 von Logger, J.G.M., de Vries, F.M. C., van Erp, P.E J., de Jong, E.M.G.J., Peppelman, M., Driessen, R.J.B.

Volltext

Comparison of the 1‐ and 5‐year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTU... von Zweegers, J., Groenewoud, J.M.M., Reek, J.M.P.A., Otero, M.E., Kerkhof, P.C.M., Driessen, R.J.B., Lümig, P.P.M., Njoo, M.D., Ossenkoppele, P.M., Mommers, J.M., Koetsier, M.I.A., Arnold, W.P., Andriessen, M.P.M., Kuijpers, A.L.A., Berends, M.A.M., Kievit, W., Jong, E.M.G.J.

Volltext

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etaner... von Vries, A.C.Q., Thio, H.B., Kort, W.J.A., Opmeer, B.C., Stok, H.M., Jong, E.M.G.J., Horvath, B., Busschbach, J.J.V., Nijsten, T.E.C., Spuls, Ph.I.

Volltext